Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-414 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-415 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
filingDate |
2015-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1c0e6ebff58e02cd1e4a8ebca73bbee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc7963b3da35466fa4ac7848ba8757c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f68dd5c91876396a1b12449677cf3b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec3179fd215e50f9162fda604dd3cee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df976c068dda32a780741dfb22114fc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_129b4d3ea88bc2c4b0a4bbba2cd3d2ed |
publicationDate |
2016-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016029948-A1 |
titleOfInvention |
Functional near-infrared fluorescence lymphatic mapping for diagnosing, accessing, monitoring and directing therapy of lymphatic disorders |
abstract |
Methods and imaging agents are used to functionally image lymph structures and to identify, diagnose, assess, monitor and direct therapies for lymphatic disorders. Embodiments of the methods utilize highly sensitive optical imaging and fluorescent spectroscopy techniques capable of rapid temporal resolution to non-invasively track or monitor packets of imaging agents flowing in one or more lymphatic structures in human patients to provide quantitative information regarding lymph propulsion and functionality of the lymphatic structures. An imaging agent comprises a fluorophore labeled peptide capable of binding integrin α 9 β 1 on a lymphatic structure. |
priorityDate |
2009-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |